---
figid: PMC9106028__cancers-14-02049-g001
figtitle: 'Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective on
  the Current Algorithm and Future Directions'
organisms:
- Homo sapiens
pmcid: PMC9106028
filename: cancers-14-02049-g001.jpg
figlink: /pmc/articles/PMC9106028/figure/cancers-14-02049-f001/
number: F1
caption: 'Mechanism of action of experimental and Food and Drug Administration-approved
  drugs. In this figure, only the major molecules in each pathway are depicted. Created
  with BioRender.com. Abbreviations: FGF—fibroblast growth factor; FGFR—FGF receptor;
  PDGF—platelet-derived growth factor receptor; PDGFR—PDGF receptor; VEGF—vascular
  endothelial growth factor; VEGFR—VEGF receptor; MET—hepatocyte growth factor receptor;
  RTK—receptor tyrosine kinase; PI3K—phosphoinositide 3-kinase; AKT—protein kinase
  B; mTOR—mechanistic target of rapamycin complex; APC—antigen-presenting cell; PD-1—programmed
  cell death protein; PD-L1—PD-1 ligand 1; PD-L2—PD-1 ligand 2; HIF—hypoxia-inducible
  factor; HRE—hypoxia response element; pVHL—von Hippel–Lindau protein.'
papertitle: 'Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective
  on the Current Algorithm and Future Directions.'
reftext: Ameish Govindarajan, et al. Cancers (Basel). 2022 May;14(9):2049.
year: '2022'
doi: 10.3390/cancers14092049
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: renal cell carcinoma | targeted therapy | immunotherapy
automl_pathway: 0.9461024
figid_alias: PMC9106028__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9106028__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9106028__cancers-14-02049-g001.html
  '@type': Dataset
  description: 'Mechanism of action of experimental and Food and Drug Administration-approved
    drugs. In this figure, only the major molecules in each pathway are depicted.
    Created with BioRender.com. Abbreviations: FGF—fibroblast growth factor; FGFR—FGF
    receptor; PDGF—platelet-derived growth factor receptor; PDGFR—PDGF receptor; VEGF—vascular
    endothelial growth factor; VEGFR—VEGF receptor; MET—hepatocyte growth factor receptor;
    RTK—receptor tyrosine kinase; PI3K—phosphoinositide 3-kinase; AKT—protein kinase
    B; mTOR—mechanistic target of rapamycin complex; APC—antigen-presenting cell;
    PD-1—programmed cell death protein; PD-L1—PD-1 ligand 1; PD-L2—PD-1 ligand 2;
    HIF—hypoxia-inducible factor; HRE—hypoxia response element; pVHL—von Hippel–Lindau
    protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PDGFRB
  - PDGFRA
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - KDR
  - FLT1
  - FLT4
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - AXL
  - CTLA4
  - APC
  - PROC
  - CD274
  - PDCD1LG2
  - VHL
  - CASR
  - CXADR
  - PRKAR1A
  - SPG7
  - NR1I3
  - TRIM13
  - CXADRP1
  - CARTPT
---
